Transcript FemCap

Preventing Pregnancy and
STIs/HIV, by Novel and Unique
Approach
Alfred Shihata, MD
Current Problems
• No Cure
• No Vaccine
• Condom is not an option for
many women
• So far Microbicides, have
failed
The Condom
Microbicides
• Kill the HIV virus in the in-vitro
• So far microbicides are not proven to
be effective in the vagina
• N-9 and Cellulose sulfate increased
the HIV transmission when compared
to placebo
• Pro-2000,Buffergel,and Carragaurd
were safe but not effective
Valuable Lessons
from the Microbicides
clinical trials
We must not forget…
• Anatomy
• Physiology
• Immunology
of the cervix and the vagina
Anatomy and Physiology
of the Vagina
Immunology
Unlike all other viruses, the HIV
virus attacks and destroys the
immune cells.
Therefore the more immune
cells at the cervix, the higher the
risk for HIV transmission.
Microbicides irritate the cervix and
provoke an immune response
Objectives for STI/ HIV prevention
by this new dual strategy
• It must be woman-controlled, and coitally
independent.
• To kill the HIV virus before it enters the cervical or
vaginal cells.
• To shield the cervix and vagina from HIV invasion
and microbicide irritation.
• Eliminate or minimize contact of the HIV virus to
the genital mucous membrane .
• To prevent pregnancy.
Microbicides still hold the best
promise for HIV prevention
The FemCap is designed to
enhance the safety and
efficacy of microbicides
Criteria for the ideal Microbicide
 Should be gentle enough not to irritate the
cervix or provoke an immune response
 It should be strong enough to kill the STIs and
HIV microorganisms
 It should NOT disrupt the vaginal
ecosystem.
 Stronger is not better
The FemCap
prevents
sperm and
STI/HIV from
entering the
cervix
The FemCap’s Microbicide
Delivery System Mimics Test Tube Condition
This unique delivery system is facing the vaginal
opening to protect the cervix.
Uterus
(Womb)
The FemCap
covering the
cervix
Vagina
The FemCap
effectively
protects the
cervix and
prevents
sperm,
bacteria and
viruses from
entering the
cervix
New Delivery System
FemCap
FemCap with Microbicide
& Gentian Violet
Healthy
Cervix and
Vagina
FemCap +
Microbicide /
Gentian Violet
dye left in situ
for 6 hours
Microbicide /
Gentian Violet dye
in the FemCap
Delivery System
Cervix and
Vagina after
removal of
FemCap
Result, No
stain was
visible over
the cervix
Facts
1. HIV virus is very fragile in-vitro.
2. The cervix is the main portal of entry to the
HIV virus.
3. Thus far all Microbicides have failed
4. Microbicides applied by applicator or
diaphragm may elicit an immune response
and disrupt the vaginal ecology.
5. Many people do not accept the condom due
to interruption of spontaneity and reduced
sexual sensations.
FemCap
• The FemCap does not interrupt spontaneity or
reduce sexual pleasure to both partners.
• It is a fit and forget for 48 hours.
• It is woman-controlled and coitally independent.
• It is re-usable for one-two years, and does not
pose any environmental hazards
• It is FDA approved, inexpensive and made of nonallergenic materials
Feasibility and acceptability of cervical
barriers (CB) among vulnerable youth:
in Africa, A pilot study in Zimbabwe
FemCap
CB Practice Results (n=45)
(n=16)
Inserted properly at first attempt (%)
81.3
Removed properly (%)
93.8
Liked the device she tried (%)
87.5
February 7, 2007 (Revised)
US Principal Investigator: Ariane van der Straten, PhD, MPH
Women’s Global Health Imperative
Department of Obstetrics, Gynecology and Reproductive Sciences
University of California, San Francisco
Zimbabwe Principal Investigator: Michael Chirenje, MD, MRCOG, FRCOG
University of Zimbabwe: University of California, San Francisco
Collaborative Programme in Women’s Health
In Summary
This dual strategy of
FemCap/Microibicide can
potentially achieve the
three critical goals:
1. Prevent HIV transmission
2. STI infections
3. Prevent Pregnancy
PREGNANCY
HIV
STI